Prot #NU MOF20C02/MCC 20487: Phase I/II Study of Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in the Management of HER2+ Breast Leptomeningeal Disease

Project: Research project

Project Details

StatusActive
Effective start/end date8/10/218/10/24

Funding

  • H. Lee Moffitt Cancer Center & Research Institute (Prot #NU MOF20C02/MCC 20487)
  • Genentech, Inc. (Prot #NU MOF20C02/MCC 20487)